FI955587A - Kemiska föreningar - Google Patents

Kemiska föreningar Download PDF

Info

Publication number
FI955587A
FI955587A FI955587A FI955587A FI955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A FI 955587 A FI955587 A FI 955587A
Authority
FI
Finland
Prior art keywords
chemical compounds
compounds
chemical
Prior art date
Application number
FI955587A
Other languages
English (en)
Finnish (fi)
Other versions
FI955587A0 (sv
Inventor
Peter Clive Cherry
John Derek Cocker
Andrew David Searle
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of FI955587A publication Critical patent/FI955587A/sv
Publication of FI955587A0 publication Critical patent/FI955587A0/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
FI955587A 1993-05-21 1995-11-20 Kemiska föreningar FI955587A0 (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB939310635A GB9310635D0 (en) 1993-05-21 1993-05-21 Chemical compounds
PCT/EP1994/001613 WO1994027989A1 (en) 1993-05-21 1994-05-19 Carbazole derivatives with 17,20-lyase-inhibiting activity

Publications (2)

Publication Number Publication Date
FI955587A true FI955587A (sv) 1995-11-20
FI955587A0 FI955587A0 (sv) 1995-11-20

Family

ID=10736007

Family Applications (1)

Application Number Title Priority Date Filing Date
FI955587A FI955587A0 (sv) 1993-05-21 1995-11-20 Kemiska föreningar

Country Status (19)

Country Link
EP (1) EP0699196A1 (sv)
JP (1) JPH08510455A (sv)
CN (1) CN1126473A (sv)
AU (1) AU6928794A (sv)
BG (1) BG100154A (sv)
CA (1) CA2162921A1 (sv)
CZ (1) CZ305195A3 (sv)
FI (1) FI955587A0 (sv)
GB (1) GB9310635D0 (sv)
HU (1) HUT73790A (sv)
IL (1) IL109703A0 (sv)
NO (1) NO954681L (sv)
OA (1) OA10195A (sv)
PE (1) PE31195A1 (sv)
PL (1) PL311702A1 (sv)
SK (1) SK142495A3 (sv)
TW (1) TW279866B (sv)
WO (1) WO1994027989A1 (sv)
ZA (1) ZA943494B (sv)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ273681A (en) * 1993-09-30 1996-09-25 Yamanouchi Pharma Co Ltd Fluoroenylmethylazole derivatives (including tricyclic ring systems where the middle ring is heterosubstituted)
WO1996014090A1 (en) * 1994-11-07 1996-05-17 Janssen Pharmaceutica N.V. Compositions comprising carbazoles and cyclodextrins
HUP9801158A3 (en) * 1995-03-01 1999-11-29 Yamanouchi Pharma Co Ltd Imidazole derivatives and medicinal composition thereof
US6420375B1 (en) * 1997-02-21 2002-07-16 Takeda Chemical Industries, Ltd. Fused ring compounds, process for producing the same and use thereof
AU2002214296C1 (en) 2000-11-17 2006-04-13 Takeda Pharmaceutical Company Limited Novel imidazole derivatives, production method thereof and use thereof
AU2002214320A1 (en) 2000-11-20 2002-05-27 Takeda Chemical Industries Ltd. Imidazole derivatives, process for their preparation and their use
ATE440096T1 (de) 2000-12-08 2009-09-15 Takeda Pharmaceutical Substituierte thiazolderivate mit 3- pyridylgruppen, verfahren zu deren herstellung und deren verwendung
EP1902026B1 (en) 2005-06-24 2010-02-17 Eli Lilly And Company Tetrahydrocarbazole derivatives useful as androgen receptor modulators (sarm)
GB0525323D0 (en) * 2005-12-13 2006-01-18 Sterix Ltd Compound
US8093279B2 (en) 2005-12-13 2012-01-10 Gillian Reed, legal representative Compound
CN100586932C (zh) * 2007-01-26 2010-02-03 中国医学科学院医药生物技术研究所 抗肿瘤化合物及其制备方法
UA105794C2 (uk) 2009-06-26 2014-06-25 Новартіс Аг 1,3-ДИЗАМІЩЕНІ ПОХІДНІ ІМІДАЗОЛІДИН-2-ОНУ ЯК ІНГІБІТОРИ Cyp17
CA2788907A1 (en) 2010-02-04 2011-08-11 Radius Health, Inc. Selective androgen receptor modulators
EP3106159A1 (en) 2010-05-12 2016-12-21 Radius Health, Inc. Therapeutic regimens
EP2600855A2 (en) 2010-08-04 2013-06-12 Pellficure Pharmaceuticals, Inc. Combination therapy for the treatment of prostate carcinoma
EP2627648A1 (en) 2010-09-16 2013-08-21 Novartis AG 17aHYDROXYLASE/C17,20-LYASE INHIBITORS
US9133182B2 (en) 2010-09-28 2015-09-15 Radius Health, Inc. Selective androgen receptor modulators
MX359399B (es) 2011-04-28 2018-09-27 Novartis Ag Inhibidores de 17alfa-hidroxilasa/c17-20-liasa.
US9492460B2 (en) * 2013-02-27 2016-11-15 Bristol-Myers Squibb Company Carbazole compounds useful as bromodomain inhibitors
AU2014241816B9 (en) 2013-03-14 2019-02-14 Pellficure Pharmaceuticals Inc. Novel therapy for prostate carcinoma
US9421264B2 (en) 2014-03-28 2016-08-23 Duke University Method of treating cancer using selective estrogen receptor modulators
CA2943611A1 (en) 2014-03-28 2015-10-01 Duke University Method of treating cancer using selective estrogen receptor modulators
CA2960750A1 (en) 2014-09-12 2016-03-17 Pellficure Pharmaceuticals, Inc. Compositions and methods for treatment of prostate carcinoma
RU2022108295A (ru) 2016-06-22 2022-04-06 Эллипсес Фарма Лтд Способы лечения ar+ рака молочной железы
AU2017350690A1 (en) 2016-10-24 2019-06-13 Pellficure Pharmaceuticals Inc. Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione
KR102557321B1 (ko) 2017-01-05 2023-07-18 래디어스 파마슈티컬스, 인코포레이티드 Rad1901-2hcl의 다형 형태

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CS229934B2 (en) * 1981-07-07 1984-07-16 Pfizer Production method subst.indolylacryte acid derivative
GB8518743D0 (en) * 1985-07-24 1985-08-29 Glaxo Group Ltd Heterocyclic compounds

Also Published As

Publication number Publication date
BG100154A (en) 1996-07-31
AU6928794A (en) 1994-12-20
CN1126473A (zh) 1996-07-10
NO954681D0 (no) 1995-11-20
PE31195A1 (es) 1995-10-18
GB9310635D0 (en) 1993-07-07
HUT73790A (en) 1996-09-30
PL311702A1 (en) 1996-03-04
IL109703A0 (en) 1994-08-26
CA2162921A1 (en) 1994-12-08
JPH08510455A (ja) 1996-11-05
WO1994027989A1 (en) 1994-12-08
OA10195A (en) 1996-12-18
TW279866B (sv) 1996-07-01
ZA943494B (en) 1995-01-23
SK142495A3 (en) 1996-06-05
EP0699196A1 (en) 1996-03-06
FI955587A0 (sv) 1995-11-20
HU9503321D0 (en) 1996-01-29
NO954681L (no) 1995-11-20
CZ305195A3 (en) 1996-06-12

Similar Documents

Publication Publication Date Title
FI955587A0 (sv) Kemiska föreningar
MX9101375A (es) Compuestos quimicos
FI922424A (fi) Kemiska foereningar
BR1101108A (pt) Composto
ID15985A (id) Senyawa kimia
MX9202262A (es) Compuestos quimicos.
DK72693D0 (da) Compounds
NO951433D0 (no) Kjemiske forbindelser
FI945907A0 (sv) Kemiska föreningar
FI932571A (fi) Kemisk process
DK124393D0 (da) Compounds
FI944825A0 (sv) Fenylbenzoamidbaserade fungicidföreningar
DE59409946D1 (de) Antidröhnmassen.
FI961520A (sv) Herbicida azabisfosfonsyraföreningar
KR970707090A (ko) 18-노르-비타민 D 화합물(18-Nor-Vitamin D Compounds)
MX9205851A (es) Compuestos quimicos
NO962264D0 (no) Kjemiske forbindelser
FI954399A (sv) Kemisk process
DK244090D0 (da) Kemiske forbindelser
ITRM940566A0 (it) Composti organici
DK150591D0 (da) Kemisk forbindelse
DK85393D0 (da) Kemisk forbindelse
DK39992D0 (da) Kemiske forbindelser
DK102693D0 (da) Novel compounds
KR950013225U (ko) 약탕 증류기

Legal Events

Date Code Title Description
FD Application lapsed